| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $99.3M | +11.3% |
| SG&A Expense | $57.9M | -10.2% |
| Operating Income | -$157.1M | -7.5% |
| Pre-tax Income | -$154.5M | -6.1% |
| Income Tax | $74K | — |
| Net Income | -$154.5M | -6.2% |
| EPS (Basic) | -$1.56 | -5.4% |
| EPS (Diluted) | -$1.56 | -5.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.4M | +100.1% |
| Short-term Investments | $117.2M | -56.8% |
| Current Assets | $190.6M | -39.9% |
| Total Assets | $308.4M | -29.9% |
| Current Liabilities | $32.2M | +51.2% |
| Total Liabilities | $126.9M | +2.7% |
| Stockholders' Equity | $181.5M | -42.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$108.1M | -0.2% |
| Capital Expenditures | $11.8M | -21.9% |
| Investing Cash Flow | $141.7M | +80.1% |
| Financing Cash Flow | $607K | -74.7% |
| Free Cash Flow | -$119.9M | +2.5% |